Predictors of major adverse cardiovascular events in patients with wild-type transthyretin amyloid cardiomyopathy: insights from a regional hospital experience
Population
45 patients diagnosed with wild-type transthyretin amyloid cardiomyopathy, mean age 80±6 years, 91% male…
Design
Cohort
Follow-up
18 months
Key result
In ATTR-CA patients, atrial fibrillation (OR 24.83) and chronic kidney disease (OR 7.55) independently predicted 18-month MACE, mainly heart failure hospitalizations.
Authors
Loading...
AF and CKD may flag higher MACE risk in ATTR-CA; hypothesis-generating in small retrospective cohort, needs prospective validation.
In patients with wild-type ATTR-CA, atrial fibrillation, chronic kidney disease, lower left atrial strain, and higher NT-proBNP are significant predictors of 18-month major adverse cardiovascular events.
Martins et al. (2025) studied this question. In ATTR-CA patients, atrial fibrillation (OR 24.83) and chronic kidney disease (OR 7.55) independently predicted 18-month MACE, mainly heart failure hospitalizations.